Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine. It was approved in Japan for use in the treatment of allergic rhinitis and urticarial or pruritus in July 2000 and January 2002, respectively

Market Analysis and Insights: Global Bepotastine Market
In 2020, the global Bepotastine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Bepotastine Scope and Market Size
The global Bepotastine market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Bepotastine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Oral
Topical

Segment by Application
Hospital
Drug Store

By Company
Sama Pharmaceuticals
Sam Chun Dang Pharm
Bausch Health
Abbott
Dong-A Pharmaceutical
Mitsubishi Tanabe Pharma
Tianjin Tanabe Seiyaku

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE